Indian ‘Mantra’ for USA to make Robotic Surgery Affordable and Accessible there
MedTech Startup Files FDA 510(k) for Homegrown Surgical Robot SSIMantra New Delhi: Indian medtech company SS Innovations, maker of surgical robot SSIMantra has moved ahead to become emblem of affordability…
Centre draws a price line to curb cheap pharma imports
New Delhi: The Indian government has set a minimum import price (MIP) for certain key pharmaceutical inputs to combat aggressive undercutting and dumping from Chinese manufacturers. The government imposed the…
47 Himachal-made medicines fail quality tests, companies asked to recall stock
These samples were part of a larger batch of 200 drugs tested nationwide that were found to be below standard, prompting the Central Drugs Standard Control Organisation (CDSCO) to issue…
Swell of Footfalls for Respiratory & Cardiac Emergencies in Aakash Healthcare due to Pollution
Experts of the Multispecialty Hospital warn of the Consequences for Children and Elderly New Delhi: Pollution woes in Delhi are piling up and showing in hospitals. Swell of footfalls in…
Early Morning Drowsy Road Drivers Beware! Maybe headed to ‘Air Crash’
Aakash Healthcare averted long term Complications from ‘Aviator’s Fracture’ New Delhi: Sleep deprivation is making both pilots and drivers on the road prone to ‘crash’. 21 year old sleep starved…
Granules India arm gets 5 USFDA observations for Hyderabad facility
Telangana: Granules India has announced that the U.S. Food and Drug Administration (FDA) has concluded an inspection with five observations at the Hyderabad facility of Granules Life Sciences, a wholly…
Drug regulator CDSCO flags 205 drug samples as not of standard quality in November
Central and state drug testing laboratories identified substandard and spurious medicines during routine nationwide surveillance India’s apex drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has flagged 205 drug…
Trump announces historic drug price cuts; Move likely to impact Indian pharma sector
The move aims to align American drug costs with the lowest international standards, a strategy that could significantly impact major generic suppliers like India Washington: In a major policy shift…
Aurobindo Pharma subsidiary’s plant in Andhra Pradesh issued five observations by U.S. FDA
The U.S.Food and Drug Administration has issued five observations to Aurobindo Pharma subsidiary APL Healthcare’s unit in Andhra Pradesh. The U.S.FDA inspected Unit-IV of APL Healthcare in SPSR Nellore District,…
Crackdown on Illegal Ayurvedic Syrup Factory: An Inside Look
In Madhya Pradesh’s Indore district, officials sealed an illegal Ayurvedic syrup factory located in a residential area. The factory, overseen by Surendra Singh, was found lacking a quality-test lab and…

Not mandatory to recall stocks released to the market prior to implementation of TMR: NPPA
Yashoda Medicity: Baby takes a Giant Step in just One Year
Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 crore
GLP-1 injections recalled across the US over sterility concerns
Govt allows third-party agencies to conduct departmental inspections
Fridge-free vaccines could reach more people, but there are still practical challenges in African settings
Low Bone Density in Nearly 7 in 10 Patients Pointing to High Risk of Osteoporosis
Hat Trick of PhDs in Health: Three Cheers for the Rare Researcher
Ministry declares PCI’s regulation on pharmacist recruitment, promotion and services as ultra vires
Second Documented Case of Pan-Drug Resistant Candida auris Uncovered in Kenya








